MiT family translocation carcinomas
Revision as of 10:34, 26 August 2016 by Meredithbernhard (talk | contribs)
 | This page is under construction |
Contributors
Tumor Type
Tumor Classification
Description
IHC Markers
Genomic Gain/Loss/LOH
| Chromosome | Gain/Loss/Amp | Region |
|---|---|---|
| 1 | Loss | Chr1 |
| 2 | Loss | Chr14 |
| 3 | Loss | Chr21 |
| 4 | Loss | ChrX |
| 5 | Loss | ChrY (male) |
Rearrangements
Mutations (SNV/INDEL)
From Cosmic Mutated in >20%
Mutated in 10-20%
Mutated in 5-10%
Mutated in 2-5%
mtDNA
Epigenomics (methylation)
Main Pathways Involved
Diagnosis
Prognosis
Therapeutics
Write your comments here